Response and Skin Toxicity Related Protein Signature in Late Stage Melanoma Patients after Anti-PD-1 Treatment - Biognosys

Response and Skin Toxicity Related Protein Signature in Late Stage Melanoma Patients after Anti-PD-1 Treatment

Case Studies

E-poster #1623 presented at AACR 2021

E-poster session April 10, 8:30 AM – 11:59 PM US EDT: PO.IM02.03 – Immune Checkpoints
Presenter: Kamil Sklodowski

A collaboration with:  Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy; NanoString Technologies, Seattle, WA

Abstract

 

Back to Resources overview

Helpdesk

Access our knowledge base with relevant resources and guiding information.

Contact

    Close banner

    New: Spectronaut® 17

    A Groundbreaking Increase in Identifications

    New: Spectronaut® 17

    A Groundbreaking Increase in Identifications

    Learn More